Document Detail

Real-time ophthalmoscopic findings of superselective intraophthalmic artery chemotherapy in a nonhuman primate model.
MedLine Citation:
PMID:  22084215     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To report real-time ophthalmoscopic findings during superselective intraophthalmic artery chemotherapy (SSIOAC) in a nonhuman primate model.
METHODS: Six adult male Rhesus macaques (Macacca mulatta) were randomly assigned to 1 of 2 treatment cohorts: melphalan (5 mg/30 mL) or carboplatin (30 mg/30 mL). Each animal underwent 3 separate SSIOAC procedures at 3-week intervals. Digital retinal images were obtained during each infusion. Intravenous fluorescein angiography was performed immediately after each procedure.
RESULTS: All SSIOAC procedures were successfully completed. Toxicities were equally distributed between drug cohorts. Systemic toxicities included mild bone marrow suppression in all animals and anorexia in 1. One animal had greater than 50% narrowing of the treated ophthalmic artery after its second infusion. All 18 procedures (100%) resulted in pulsatile optic nerve and choroid blanching, retinal artery narrowing, and retinal edema. Of the 18 procedures, retinal artery sheathing was found during 17 (94%), and retinal artery precipitates were seen in 10 (56%); choroidal hypoperfusion was seen by fluorescein angiogram in 18 (100%).
CONCLUSION: Real-time ophthalmic investigations are useful and, in our nonhuman primate model, indicate prevalent, acute ocular vascular toxicities during SSIOAC.
CLINICAL RELEVANCE: Real-time retinal imaging is feasible in a nonhuman primate model of SSIOAC. Application to SSIOAC in children may shed insight into reported vascular toxicities.
Matthew W Wilson; John S Jackson; Blanca X Phillips; Jacquelyn Buchanan; Sharon Frase; Fan Wang; Jena J Steinle; Clinton F Stewart; Timothy D Mandrell; Barrett G Haik; J Scott Williams
Related Documents :
10208195 - Frequency of pulmonary embolism in patients with low-probability lung scan and negative...
7781655 - The backflow from the pulmonary circulation for identification of the aortic origin of ...
7414275 - Microvasculature of the rat lung as revealed by scanning electron microscopy of corrosi...
7472945 - Experimental fetal tracheal ligation and congenital diaphragmatic hernia: a pulmonary v...
2423215 - An unusual presentation of branch retinal artery obstruction in association with ocular...
1590875 - Uteroplacental doppler flow velocity waveform indices in normal pregnancy: a statistica...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Archives of ophthalmology     Volume:  129     ISSN:  1538-3601     ISO Abbreviation:  Arch. Ophthalmol.     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-15     Completed Date:  2012-01-12     Revised Date:  2013-07-08    
Medline Journal Info:
Nlm Unique ID:  7706534     Medline TA:  Arch Ophthalmol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1458-65     Citation Subset:  AIM; IM    
Hamilton Eye Institute, University of Tennessee Health Science Center, Memphis, 38163, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antineoplastic Agents, Alkylating / administration & dosage,  toxicity*
Carboplatin / administration & dosage,  toxicity*
Chemotherapy, Cancer, Regional Perfusion*
Fluorescein Angiography
Macaca mulatta
Melphalan / administration & dosage,  toxicity*
Ophthalmic Artery / drug effects*
Retinal Diseases / chemically induced*,  diagnosis
Grant Support
P30 CA021765/CA/NCI NIH HHS; P30 EY021721/EY/NEI NIH HHS
Reg. No./Substance:
0/Antineoplastic Agents, Alkylating; 148-82-3/Melphalan; 41575-94-4/Carboplatin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Outcomes of integrating genetics in management of patients with retinoblastoma.
Next Document:  Aceruloplasminemia: retinal histopathologic manifestations and iron-mediated melanosome degradation.